259. Colleen Cutcliffe, Co-founder & CEO of Pendulum Therapeutics
Today, I'm joined by Colleen Cutcliffe, co-founder & CEO of Pendulum Therapeutics.
Backed by actress Halle Berry, Pendulum is a microbiome biotech company disrupting probiotics with doctor-formulated metabolic health supplements.
In this episode, we explore the links between gut health and metabolism.
We also cover:
• The science behind Pendulum's medical probiotics • Advocating for healthspan over healthcare • Where preventative health is headed
Subscribe to the podcast → www.insider.fitt.co/podcast
Subscribe to our newsletter → www.insider.fitt.co/subscribe
Follow us on LinkedIn → www.linkedin.com/company/fittinsider
Pendulum Therapeutics' Website: https://pendulumlife.com/
Pendulum Therapeutics' IG: https://www.instagram.com/pendulumlifeco/
Colleen's IG: https://www.instagram.com/drcolleencutcliffe/
-
The Fitt Insider Podcast is brought to you by EGYM. Visit EGYM.com to learn more about its smart workout solutions for fitness and health facilities.
Fitt Talent: https://talent.fitt.co/
Consulting: https://consulting.fitt.co/
Investments: https://capital.fitt.co/
Chapters: (00:00) Introduction (01:28) Colleen's Background and Founding Pendulum (02:02) The Science Behind Pendulum's Innovations (05:50) Product Portfolio and Market Impact (08:02) Developing and Scaling Probiotic Solutions (11:19) Consumer and Healthcare Integration (15:18) The Future of Preventative Health (28:54) Advocating for Healthspan Over Healthcare (33:21) Conclusion
You May Also Like

BFM Bourse
BFM Business

Mining Stock Daily
Trevor Hall

Faszination Freiheit
Thorsten Wittmann

Earn Your Leisure
iHeartPodcasts

Handmade Business Secrets Podcast
Zach Vaught

🇨🇭🇩🇪 Markt-Trends setzen mit Swissquote
Markus Koch, Wieland Arlt und Feyyaz Alingan bieten Ihnen einen Überblick über alle Anlageklassen

Marketplace Morning Report
Marketplace

How to Trade Stocks and Options Podcast with OVTLYR Live
Christopher M. Uhl, CMA

The Property Academy Podcast
Opes Partners

Børsmorgen & Økonominyhetene
Finansavisen
Community discussion